Tristetraprolin Upregulation Reduces Frailty and Increases Bone Density in Old Mice – Fight Aging!
Tristetraprolin Upregulation Reduces Frailty and Increases Bone Density in Old Mice Researchers here report that life-long tristetraprolin (TTP) upregulation leads to reduced frailty and improved bone mineral density in aged mice. One of the functions of TTP is that it suppresses expression of the pro-inflammatory TNF-α cytokine, so a reduced degree of age-related inflammation … Read more